Valeant Pharmaceuticals closes offering of $1.45 billion of common shares
Valeant announced the closing of its previously announced registered offering of common shares in the U.S. The Company issued 7,286,432 common shares at a price of $199.00 per share, for aggregate gross proceeds of approximately $1.45 billion. March 27, 2015